Stock info Guerbet | Filter  Basic-Info

Guerbet

The past year was a good year for Guerbet investors

Over the last 12 months, that were profitable period for the investors in Guerbet, the stock gained around 14 percent. Over the period 2011-2016 the stock rose a massive 316,92 percent. Guerbet's revenues between 2011 and 2015 were very constant and moved between 403,5 million euros and 488,74 million euros. Guerbet's net incomes between 2011 and 2015 were very volatile through the time and moved between 14,43 million euros and 40,85 million euros.

The company mostly operates in the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

Over the past 5 years the French company paid out dividends. Guerbet's dividend return over the period 2011 - 2015 was around 2,6 percent per year.

Guerbet' balance mostly financed with equity

At the end of 2015 the French company had a balance sheet of around 898,82 million euros. The total debt of the pharmaceutical company was at the end of 2015 614,97 million euros, which equals around 68,42 percent of the total balance sheet.

At the end of 2015 around 12,22 million stocks were listed.

All the annual reports of Guerbet are available here. More information about Guerbet can be found it's website. .